Vera Therapeutics, Inc (VERA) – aksjekurser og nyheter

Hvorfor har VERA gått ned? 3,24%?

Gå mer i dybden

VERA:NASDAQ

Vera Therapeutics, Inc

28,10 USD

−3,24%

(−0,94) 1 D

13. nov., 16:00:00 GMT-5 · USD

Alle symboler

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for VERA …

Åpne

28,64 USD

Høy

28,96 USD

Lav

27,85 USD

Markedsverdi

2,03 mrd.

Snittvolum

1,71 mill.

Volum

1,01 mill.

52 u høy

56,04 USD

52 u lav

26,38 USD

EPS

−5,90 USD

Beta

1,07

Utestående aksjer

72,30 mill.

Antall ansatte

362

Åpne

28,64 USD

Høy

28,96 USD

Lav

27,85 USD

Markedsverdi

2,03 mrd.

Snittvolum

1,71 mill.

Volum

1,01 mill.

52 u høy

56,04 USD

52 u lav

26,38 USD

EPS

−5,90 USD

Beta

1,07

Utestående aksjer

72,30 mill.

Antall ansatte

362

Relaterte aksjer

BEAM

Beam Therapeutics Inc

492,00 MXN

+2,38%

RXRX

Recursion Pharmaceuticals Inc

Revolution Medicines Inc

172,29 USD

−2,30%

Nyhetssaker

Fra nettkilder og nyhetspartnere

Foreign Policy Journal

for 35 minutter siden

Dow Jones Industrial Average (DJIA) Stays Green While Nasdaq Tumbles Nearly 1% In Sharp Rotation Trade

AP News

for 1 døgn siden

Microsoft outage shows the risks of relying on a single technology provider for essential services

Yahoo Finance

for 13 timer siden

SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger

24/7 Wall St.

for 4 timer siden

He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076

Om Vera Therapeutics, Inc

Administrerende direktør-

Ansatte362

Grunnlagt2016

HovedkontorBrisbane, California, USA

SektorHealth Care

Bransje-

Nettstedveratx.com

Analytiker	Anbefaling	Handling	Prismål	Anslått	Dato
Anupam Rama J.P. Morgan	Buy	Maintained	75,00 USD	+166,9%	11/12/2026
Dina Ramadane Bank of America Securities	Buy	Maintained	-	-	11/06/2026
Laura Chico Wedbush	Hold	Maintained	29,00 USD	+3,2%	11/06/2026
Pete Stavropoulos Cantor Fitzgerald	Buy	Maintained	100,00 USD	+255,9%	11/05/2026
Vamil Divan Guggenheim	Buy	Reiterated	66,00 USD	+134,9%	11/05/2026
Arthur He CFA H.C. Wainwright	Buy	Reiterated	75,00 USD	+166,9%	11/06/2026
Will Soghikian Leerink Partners	Hold	Maintained	34,00 USD	+21%	10/27/2026
Unknown Analyst Leerink Partners	Hold	Maintained	34,00 USD	+21%	10/27/2026
Paul Choi Goldman Sachs	Buy	Reiterated	80,00 USD	+184,7%	10/22/2026
Mohit Bansal Wells Fargo	Buy	Maintained	70,00 USD	+149,1%	10/15/2026
Unknown Analyst Jefferies	Buy	Maintained	59,00 USD	+110%	09/16/2026
Rami Katkhuda LifeSci Capital	Buy	Maintained	90,00 USD	+220,3%	09/15/2026
Ryan Deschner Raymond James	Buy	Maintained	-	-	09/15/2026
Ritu Baral TD Cowen	Buy	Maintained	78,00 USD	+177,6%	08/31/2026
Gavin Clark-Gartner Evercore ISI	Buy	Maintained	91,00 USD	+223,8%	07/09/2026
Unknown Analyst Wells Fargo	Buy	Maintained	70,00 USD	+149,1%	06/11/2026
Andy Chen Wolfe Research	Buy	Maintained	88,00 USD	+213,2%	06/02/2026
Unknown Analyst Wedbush	Hold	Maintained	35,00 USD	+24,6%	05/08/2026

Alle verdier i USD	des. 2025	mars 2026	juni 2026	sep. 2026
Inntekt	-	-	-	10,28 mill.
Varekostnad	-	-	-	3,30 mill.
Direkte driftskostnader	-	-	-	3,30 mill.
Utgifter til forskning og utvikling	59,31 mill.	86,01 mill.	60,08 mill.	41,25 mill.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	34,90 mill.	39,12 mill.	52,41 mill.	61,43 mill.
Driftskostnader	94,21 mill.	125,13 mill.	112,49 mill.	102,68 mill.
Totale driftskostnader	94,21 mill.	125,13 mill.	112,49 mill.	105,98 mill.
Driftsinntekter	−94,21 mill.	−125,13 mill.	−112,49 mill.	−95,70 mill.
Andre ikke-operasjonelle inntekter	−303,00k	−32,00k	−483,00k	−472,00k
EBT inkludert uvanlige elementer	−91,10 mill.	−121,03 mill.	−109,47 mill.	−93,71 mill.
EBT uten uvanlige elementer	−90,90 mill.	−120,63 mill.	−109,47 mill.	−93,71 mill.
Kostnad for inntektsskatt	1,00k	-	-	-
Faktisk avgiftssats	-	-	-	-
Andre driftskostnader	-	-	-	-
Nettoinntekt	−91,10 mill.	−121,03 mill.	−109,47 mill.	−93,71 mill.
Netto fortjenestemargin	-	-	-	−911,85 %
Resultat per aksje	−1,39	−1,69	−1,52	−1,30
Rente- og investeringsinntekter	5,52 mill.	6,36 mill.	5,35 mill.	4,34 mill.
Rentekostnader	−1,90 mill.	−1,82 mill.	−1,85 mill.	−1,87 mill.
Netto rentekostnader	3,61 mill.	4,53 mill.	3,50 mill.	2,46 mill.
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	−94,07 mill.	−124,99 mill.	−112,36 mill.	−94,88 mill.
Gevinst eller tap ved salg av eiendeler	-	-	-	-

Spør om hva som helst